Lyka Labs Limited
Lyka Labs Limited (LYKALABS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
lykalabs.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Stock price
₹76.83
Market cap
278 Cr
Stock P/E
134.8
P/B
3.02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28 Cr | 33 Cr | 28 Cr | 30 Cr | 41 Cr | 34 Cr | 33 Cr | 33 Cr | 37 Cr | 31 Cr | 28 Cr | 42 Cr |
| Operating expenses (approx.) | 24 Cr | 26 Cr | 26 Cr | 26 Cr | 36 Cr | 29 Cr | 29 Cr | 29 Cr | 39 Cr | 29 Cr | 34 Cr | 38 Cr |
| EBITDA | 4 Cr | 7 Cr | 2 Cr | 4 Cr | 5 Cr | 5 Cr | 4 Cr | 4 Cr | -3 Cr | 2 Cr | -6 Cr | 5 Cr |
| OPM % | 14.9% | 21.1% | 7.3% | 12.3% | 12.0% | 15.4% | 12.2% | 11.2% | -6.9% | 5.4% | -23.0% | 10.7% |
| Other income | 0.25 Cr | 0.54 Cr | 0.29 Cr | 0.56 Cr | 0.03 Cr | 0.83 Cr | 0.82 Cr | 0.63 Cr | 1 Cr | 1 Cr | 0.61 Cr | 0.42 Cr |
| Interest | 1 Cr | 1 Cr | 1 Cr | 0.65 Cr | 0.54 Cr | 0.61 Cr | 0.47 Cr | 0.85 Cr | 0.79 Cr | 0.82 Cr | 0.70 Cr | 1 Cr |
| Depreciation | 4 Cr | 3 Cr | 3 Cr | 2 Cr | 2 Cr | 2 Cr | 1 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr |
| Profit before tax | -0.79 Cr | 3 Cr | -2 Cr | 2 Cr | 3 Cr | 4 Cr | 3 Cr | 1 Cr | -4 Cr | -0.16 Cr | -9 Cr | 2 Cr |
| Tax % | 22.3% | 38.7% | -27.3% | 30.8% | 26.6% | 24.3% | 32.8% | 26.3% | 26.7% | 5.6% | 6.1% | -5.1% |
| Net profit | -0.62 Cr | 2 Cr | -2 Cr | 1 Cr | 2 Cr | 3 Cr | 2 Cr | 1.00 Cr | -3 Cr | -0.15 Cr | -8 Cr | 2 Cr |
| EPS (₹) | ₹-0.16 | ₹0.53 | ₹-3.83 | ₹0.40 | ₹0.58 | ₹0.75 | ₹0.49 | ₹0.25 | ₹-0.94 | ₹0.00 | ₹-2.13 | ₹0.57 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 71 Cr | 61 Cr | 86 Cr | 194 Cr | 93 Cr | 111 Cr | 138 Cr | 128 Cr | Sign in for TTM |
| Operating expenses (approx.) | 73 Cr | 65 Cr | 67 Cr | 93 Cr | 76 Cr | 95 Cr | 121 Cr | 132 Cr | Sign in for TTM |
| EBITDA | -2 Cr | -4 Cr | 20 Cr | 101 Cr | 17 Cr | 16 Cr | 18 Cr | -3 Cr | Sign in for TTM |
| OPM % | -2.7% | -6.0% | 22.8% | 52.1% | 18.1% | 14.1% | 12.9% | -2.7% | Sign in for TTM |
| Other income | 2 Cr | 3 Cr | 2 Cr | 2 Cr | 3 Cr | 1 Cr | 2 Cr | 3 Cr | Sign in for TTM |
| Interest | 7 Cr | 20 Cr | 26 Cr | 20 Cr | 12 Cr | 5 Cr | 2 Cr | 3 Cr | Sign in for TTM |
| Depreciation | 7 Cr | 8 Cr | 8 Cr | 17 Cr | 14 Cr | 13 Cr | 7 Cr | 8 Cr | Sign in for TTM |
| Profit before tax | -15 Cr | -62 Cr | -16 Cr | 60 Cr | -13 Cr | -0.93 Cr | 11 Cr | -12 Cr | Sign in for TTM |
| Tax % | 58.8% | -1.2% | 26.0% | 34.8% | 0.1% | -180.6% | 28.7% | 11.4% | Sign in for TTM |
| Net profit | -6 Cr | -63 Cr | -12 Cr | 39 Cr | -13 Cr | -3 Cr | 8 Cr | -10 Cr | Sign in for TTM |
| EPS (₹) | ₹-1.79 | ₹-27.29 | ₹-4.07 | ₹13.57 | ₹-4.63 | ₹-0.79 | ₹2.22 | ₹-2.81 | Sign in for TTM |
| Dividend payout % | — | — | — | 0.0% | — | — | 0.0% | — | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 28 Cr | 29 Cr | 29 Cr | 29 Cr | 31 Cr | 33 Cr | 36 Cr | 36 Cr |
| Reserves | 17 Cr | -43 Cr | -54 Cr | -15 Cr | 15 Cr | 35 Cr | 68 Cr | 57 Cr |
| Borrowings | 96 Cr | 141 Cr | 162 Cr | 130 Cr | 72 Cr | 57 Cr | 38 Cr | 48 Cr |
| Other liabilities | 76 Cr | 74 Cr | 53 Cr | 43 Cr | 34 Cr | 31 Cr | 35 Cr | 35 Cr |
| Total liabilities | 217 Cr | 200 Cr | 190 Cr | 186 Cr | 152 Cr | 157 Cr | 176 Cr | 175 Cr |
| Fixed assets (net) | 74 Cr | 73 Cr | 67 Cr | 69 Cr | 49 Cr | 47 Cr | 77 Cr | 80 Cr |
| CWIP | 18 Cr | 17 Cr | 16 Cr | 16 Cr | 15 Cr | 22 Cr | 0.20 Cr | 2 Cr |
| Investments | 0.02 Cr | 0.02 Cr | 0.02 Cr | 25 Cr | 0.05 Cr | 0.09 Cr | 0.04 Cr | 0.03 Cr |
| Loans & advances | 0.64 Cr | 0.08 Cr | 0.07 Cr | 0.04 Cr | 0.08 Cr | 3 Cr | 0.05 Cr | 0.05 Cr |
| Inventories | 7 Cr | 7 Cr | 4 Cr | 8 Cr | 7 Cr | 10 Cr | 12 Cr | 14 Cr |
| Trade receivables | 15 Cr | 8 Cr | 9 Cr | 18 Cr | 20 Cr | 27 Cr | 43 Cr | 35 Cr |
| Cash & bank | 2 Cr | 10 Cr | 7 Cr | 17 Cr | 12 Cr | 6 Cr | 1 Cr | 1 Cr |
| Other assets | 102 Cr | 86 Cr | 86 Cr | 32 Cr | 49 Cr | 42 Cr | 42 Cr | 42 Cr |
| Total assets | 217 Cr | 200 Cr | 190 Cr | 186 Cr | 152 Cr | 157 Cr | 176 Cr | 175 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 79 Cr | 9 Cr | 2 Cr | 2 Cr | 5 Cr |
| Cash from investing | — | — | — | 9 Cr | 7 Cr | -9 Cr | -12 Cr | -9 Cr |
| Cash from financing | — | — | — | -64 Cr | -22 Cr | 2 Cr | 5 Cr | 4 Cr |
| Net cash flow | — | — | — | 24 Cr | -5 Cr | -12 Cr | -5 Cr | 0.02 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 79 Cr | 0.77 Cr | -7 Cr | -14 Cr | -6 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | -18.4% | -9.3% | 8.3% | 55.9% | -1.1% | 3.1% | 9.5% | -6.1% |
| ROE % | -14.2% | — | — | 172.9% | 0.0% | -3.8% | 7.7% | -11.0% |
| Debtor days | 75 | 48 | 37 | 35 | 79 | 89 | 113 | 99 |
| Inventory days | 169 | 183 | 127 | 111 | 110 | 109 | 122 | 156 |
| Days payable | 557 | 461 | 435 | 325 | 148 | 137 | 147 | 192 |
| Cash conversion cycle | -313 | -231 | -271 | -180 | 40 | 60 | 89 | 63 |
| Debt / equity | 2.13 | — | — | 9.72 | 1.58 | 0.84 | 0.37 | 0.53 |
| Current ratio | 0.40 | 0.54 | 0.59 | 0.53 | 1.36 | 1.35 | 1.45 | 1.17 |
| Net debt / EBITDA | — | — | 0.00 | 0.00 | 3.56 | 3.27 | 2.04 | — |
Compare with peers
Loading peers…